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Abstract A new ligand (Ts s:) of the apamin binding site on rat 
brain synaptosomes (Ko.s = 300 pM) was purified and character- 
ized from the venom of Tityus serrulatus. It is a polypeptide toxin 
of 35 amino acid residues, with three disulfide bridges. Its cDNA 
was amplified from a venom gland cDNA library and the 
nucleotide sequence determined. A model of Ts • was constructed 
by amino acid replacement using charybdotoxin structure as 
determined by 1H nuclear magnetic resonance as starting model. 
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1. Introduction 
Scorpion venoms contain potent neurotoxins which specifi- 
cally modify ionic channel functions. Electrophysiological, 
radioactive ion flux and ligand binding studies show that 
some neurotoxins recognize different binding sites on the volt- 
age-sensitive Na ÷ channels of mammals and insects and 
others recognize various K ÷ channels [1]. Toxins active on 
K + channels are minor components of venoms. They are sin- 
gle chain polypeptides of 30~0 amino acid residues, with 
three disulfide bridges [2]. They are useful tools for investigat- 
ing the mechanisms of ion conduction, channel selectivity and 
architecture of the pore region of the K + channels [3-5]. In 
this group, those able to compete with apamin (a neurotoxin 
from bee venom, 18 residues, two disulfide bridges) to small 
conductance calcium activated K ÷ channels (SKCa) [6] are 
the smallest described scorpion toxins. Leiurotoxin I (LTX 
1) [7,8] and P05 [9] are 31 residues long, with differences at 
only three positions. 1H nuclear magnetic resonance (NMR) 
analysis of P05 [10] has demonstrated that these molecules are 
composed of an a-helix (residues 5-14) connected at a tight 
turn to a two-stranded antiparallel ]]-sheet (sequences 17-22 
and 25-29). Chemical synthesis of analogs [9,11] and modifi- 
cations of charged residues [8] shows that three Arg residues, 
in the solvent-exposed side of the a-helix, constitute a highly 
positively charged surface involved in the pharmacological 
activity of P05 or LTX 1. A multipoint interaction with the 
receptor is likely. A pair of Arg residues is also crucial for the 
pharmacological ctivity of apamin [6]. We report the purifi- 
cation from the venom of the South american scorpion Tityus 
serrulatus (Ts) of a new inhibitor of [a2SI]apamin binding to 
rat brain synaptosomes. It is a peptide dissimilar to LTX 1 
and P05. The corresponding cDNA sequence was determined. 
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2. Materials and methods 
The Ts venom (0.98 g), obtained from scorpions collected near 
Santa Barbara, was a gift from Dr. C.R. Diniz, Instituto E. Diaz, 
Belo Horizonte, M.G., Brazil. Apamin was purchased from Sigma. 
Kaliotoxin (KTX) was synthesized in the laboratory. Other solvents 
and reagents were analytical grade commercial products from Sigma 
and Merck. Na[125I] was from Amersham Corp. 
2.1. Purification of Ts lc 
The venom was dialysed against distilled water to eliminate salts 
and small peptides (24 h, 4°C, 1 liter× 5, using Spectrapor 3 mem- 
brane with a mol. wt. cut-off< 1000). The HPLC experiments were 
performed as previously described [12] with a Millipore/Waters As- 
sociates ystem. After gel filtration through Sephadex G-50, the sam- 
ple was loaded onto a Merck 4 × 250 mm analytical high pressure 
liquid chromatography (HPLC) column (Lichrospher, 5 Ixm, 100 
RP-18). Solvent A was 0.1% TFA (v/v) in water and solvent B was 
0.1% TFA (v/v) in acetonitrile. 
2.2. Competition assays using rat brain synaptosomes 
Each HPLC fraction was tested in competition assays for binding 
to rat brain synaptosomal fraction (P2) with mono[125I]apamin ac- 
cording to [13] or [12SI]KTX [12]. To study only ligands exhibiting 
the highest affinity for the apamin receptor, purified fractions were 
screened at a final dilution of 5 × 10 -5. 
2.3. Chemical characterization 
Amino acid composition determinations and automatic sequencing 
were as described [12]. 
2.4. Construction of the cDNA library 
Standard recombinant DNA techniques were used [14]. Enzymes 
were from Biolabs. The construction of the venom gland cDNA li- 
brary ~,gt 10 (Promega) has been described in detail [15]. The library 
contained 2.5 × 106 independent phage clones. 
2.5. Polymerase chain reaction ( PCR) 
PCR was used for amplification from the library of the cDNA 
encoding the Ts ~ as previously described [16]. The primers used for 
PCR amplifications were the following: for the first amplification, 
reverse primer 1, 5'-CAA/G TCA/G CAC/T CTT/A CCG TTA/C 
GTA/G CAT TT-3'; forward primer 2, 5'-CT TTT GAG CAA 
GTT CAG CCT GGT TAA GT-3'; forward primer 3, 5'-T CAA 
TTC TGA TAA TAC GAA AAC ATG-3'; reverse primer 4, 5'- 
GAG GTG GCT TAT GAG TAT TTC TTC CAG GGT A-3'. 
The product with the appropriate size was recovered, purified using 
the Wizard PCR Prep DNA Purification System (Promega) and ream- 
plified by a second PCR reaction in the same conditions. 
2.6. Sequence analysis of PCR products 
The purified PCR products were filled in with dNTPs using the 
Klenow fragment according to standard methods [14], and ligated 
into the vector pBlueScript SK + (Stratagene). The recombinant clones 
were analyzed using standard techniques [14] and sequenced using 
sequenase (US Biochemicals) and the Sanger dideoxynucleotide chain 
termination method [14]. 
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2. 7. Modelling 
The TURBO-FRODO [17] and X-PLOR 3.1 [18] programs were 
used for construction and refinement of the model, respectively. The 
model of Ts 1< was deduced from the structure of charybdotoxin 
(ChTX) in solution previously determined by XH-NMR [19]. After 
amino acid residue replacement, the starting model was refined by 
1,0 
0,5 
0,0e 
A 
i ~ ' '"" 
: I ~ OD280nm 
125I Apa bound B/B0 
100 200 
Fraction number 
CI 
o 
O 
20 40 60 80 
i::J o ] '8°1  / 60 
R 20 0!., 
-16 -14-12-10  -8 -6 -4 -2 
Log (Tox) 
20 40 60 80  
T ime ( ra in )  
Fig. 1. Purification of Ts ~. (A) Gel filtration through three columns 
(2.5× 100 cm) in series; Sephadex G-50 fine in 30% acetic acid, flow 
rate: 40 ml/h. The fraction able to compete with [125I]apamin speci- 
fically bound to its receptor site on rat brain synaptosomal mem- 
branes is indicated with a dotted line. (B) Reverse-phase chromato- 
graphy of the previous fraction (1/80% of the optical density 
obtained at 280 nm) in a linear gradient of 5-50% B in A for 60 
min and 50-80% B in A for 5 min; flow rate 1 ml/min. 1 optical 
density unit full scale (ODvFS) at 230 nm. Arrow indicates the frac- 
tion (RT=31 min) able to compete for [l~SI]apamin binding. (C) 
Reverse-phase of the entire fraction RT=31 rain, by isocratic 
HPLC with solvent B (18%) in solvent A for 60 min. 10DvFS at 
230 nm and 280 nm. A component with inhibitory binding activity 
was recovered in the peak with a RT = 20 min and was called Ts n. 
Inset: Inhibition of [125I]apamin binding to rat brain synaptosomal 
fraction. In the competition assay, 0.1 nM [125I]apamin (50 /.tl) and 
synaptosomes (400 ~tl at 0.4 mg of protein/ml) were incubated for 1 
h at 0°C with 50 ml of each of a series of concentrations of native 
apamin or Ts 1<. The incubation buffer was 25 mM Tris-HCl and 
10 mM KC1, pH 7.2. The experiment was stopped by centrifugation 
at 11 000 ×g for 3 min. The membrane pellets were washed twice 
with 1 ml of cold washing buffer and the radioactivity bound to the 
membrane was counted. B0 is the binding of [125I]apamin i the ab- 
sence of competitor and B is the binding in the presence of the indi- 
cated concentrations of native apamin (e) or Ts 1< (©). Non-specific 
binding was less than 10%. Data points correspond to duplicates 
from which non-specific binding has been subtracted. The standard 
error of the mean of the data was around 5%. 
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TTTTATATTCAATTCTGATAATACGAAAAAC ATG AAA GTT TTA 5TsAI3 
TCAATTCTGATAATACGAAAAA¢ ATG AAA GTT TTA 3T8I I .8  
M K V L 
-20 
TAT  GGT ATT  CTG ATC ATA TTT  ATC TTA TGT TCA ATG 5TsAI3 
TAT GGT ATT  CTG ATC ATA TTT  ATC TTA TGT TCA ATG 3T8I I .8  
Y G I L I I F I L C S M 
-15 -i0 
TTT  TAT  TTA AGC CAA GAA GTT GTT ATA GGT CAA AGA 5TSAI3 
TTT  TAT  TTA AGC CAA GAA GTT GTT ATA GGT CAA AGA 3TBI I .8  
F Y L S Q E V V I G Q R 
-5 +i +5 
TGT TAC AGA TCG CCT GAC TGT TAT TCA GCG TGT AAG 5TsAI3 
TGT TAC AGA TCG CCT GAC TGT TAT TCA GCG TGT AAG 3Ts I I .8  
C Y R S P D C Y S A C K 
+i0 +15 
AAA CTT  GTA GGA AAG GCT ACA GGC AAA TQT ACT AAC 5TSAI3 
AAA CTT  GTA GGA AAG GCT ACA GGC AAA TGT ACA AAT 3TaI I .8  
K L V G K A T G K C T N 
+20 +25 +30 
GGA AGA TGC GAC TG 5TsAI3 
GGC AGA TGC GAC TGT TAA ACATAACTCTACTGTTTGCGTAA 3TBXI .8  
G R C D C End  
+35 
AAGAGTAATAC ATGTATTTGATTATTGTATAC TAAGCAC TGAATCAT 3TBII .  8 
GTAATTTTCGCAAGC TAAC GTGTTAATTG TAAAATATTTTACACAGT 3TBII.  8 
TTC ATATTCAAC AGATTC TACAGTGTAAGTATGTTC AGTTAAAATAG 3TsII.  8 
TTGTCAAAATTTAAAC ATGAT TTGATGTTATGC ATGTAATGAATTCG 3TBII.  8 
AC ACAAATGCC TC CCGCTTTTGATAAAAAGTAACTTAAGATTCTAAT 3TsII .  8 
GACCAGATTCTGTATTGCTTTCTT 3TBII.  8 
Fig. 2. Nucleotide sequence of the cDNA encoding the Ts ~ precur- 
sor. The predicted protein sequence is given below the nucleotide se- 
quence and is numbered starting from the NH2-terminal amino acid 
residue of the toxin; primers 1 and 3 are underlined. 5TsA13 and 
3TsII.8 are the sequences obtained after the first and the second 
PCR respectively. 
10000 steps of Powell minimizer to correct geometry and Van der 
Waals as well as electrostatic interactions. 
3. Results and discussion 
Ts venom was subjected to chromatography: a gel filtration 
through Sephadex G-50. One fraction competed for the apa- 
min binding site (Fig. 1A). Further separation of this fraction 
using reverse-phase HPLC led to an heterogeneous diagram 
(Fig. 1B). One fraction with a retention time (RT) of 31 min 
specifically bound to the apamin binding site. This fraction 
was loaded onto a RP-C18 column for isocratic purification 
(Fig. 1C). One peak (RT=20 min) competed with 
[125I]apamin binding. The corresponding protein constituted 
0.25% of the weight of the crude venom. It was a peptide of 
35 residues, named Ts n (from Ts Kapa, i.e. K for K + chan- 
nels and apa for apamin) with the following amino acid com- 
position: Asx, 2.97 (3), Thr, 2.13 (2), Ser 2.20 (2), Pro, 1.10 
(1), Glx, 1.31 (1), Gly, 4.65 (5), Ala, 2.02, (2), Cys, 5.34 (6), 
Val, 1.65 (2), Ile, 0.88 (1), Leu, 1.20 (1), Tyr, 1.52 (2), Lys, 
3.82 (4), Arg, 2.75 (3), no Met, Phe or His. Its activity was 
assayed on rat brain synaptosomes (Fig. 1C, inset). It inhib- 
ited [125I]apamin binding with a /(0.5 value of 300 pM (Ko.5 
values of: apamin = 8 pM, P05 = 20 pM, LTX 1 = 400 pM). 
To determine the sequence of Ts ~:, 1 nmol of native toxin was 
subjected to Edman degradation. The initial Edman degrada- 
tion yield was 46.1% and the repetitive yield was 92.8%. Iden- 
tification of the amino acid was possible up to the 34th resi- 
due, except positions 7, 13, 17, 28, 33, which, by homology to 
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Fig. 3. Sequence identities between Ts 1< and other scorpion toxins 
acting on K + channels. Sequence comparison of Ts ~ (this work) 
and other scorpion toxins acting on different ypes of K + channels: 
toxins specific for the small conductance Ca 2+ activated K+ chan- 
nels: apamin from bee venom [6]; LTX1 [7] or P05 [9]. See refer- 
ences for the other toxins in Miller [2]: ChTX, charybdotoxin from 
Leiurus quiquestriatus hebraeus; IbTX, iberiotoxin from Buthus ta- 
mulus; NTX, noxiustoxin from Centruroides noxius; MgTX, marga- 
toxin from Centruroides margaritus; KTX, kaliotoxin from Androc- 
tonus mauretanicus mauretanicus; AgTxl, 2, 3, agitoxin 1, 2 and 3 
from Leiurus quiquestriatus hebraeus; KTX2, kaliotoxin 2 from An- 
droctonus australis, Ts Kot, tityus toxin Kot from Tityus serrulatus; 
identical residues are in bold; *, C-amidated residue. 
other small scorpion toxins, should be Cys. The sequence was 
the following: VVIGQRXYRSPDXYSAXKKLVGKATGK- 
XTNGRXD. To confirm the amino acid sequence and to help 
predict the structure of the toxin precursor, the sequence of 
the cDNA encoding Ts 1< was determined. 
The Ts 1¢ cDNA was obtained by PCR. A degenerate oli- 
gonucleotide based on the C-terminal region (from Lys 27 to 
Cys 35) was used as a reverse primer with a forward primer 
corresponding to the phage ~,gtl0 sequence (primers 1 and 2), 
A total cDNA library transcribed from venom gland mRNA 
was used as template. A 280 bp product was obtained. It 
encompassed an open reading frame corresponding to the 
N-terminal part of Ts ~¢ (residues 1-27) and an upstream 
sequence ncoding a putative signal peptide. Based on this 
sequence, primer 3, corresponding to the 5' non-coding part 
of the clone, was used in a new PCR with the reverse primer 4 
corresponding to the phage kgtl0. A 550 bp PCR-amplified 
product was obtained. This second PCR product encoded an 
open reading frame corresponding to a Ts ~: precursor of 57 
amino acid residues (Fig. 2). Its organization is similar to that 
of the precursors of 'long' and 'short' scorpion toxins [12,20]. 
The deduced sequence of the mature Ts 1< was identical to that 
determined by Edman degradation, with 22 residues encoded 
upstream from the NH2-terminal Val. As far as we know, 
signal peptides never terminate with Glu [21]. So, the pre- 
dicted precursor could be composed of a signal peptide prob- 
ably terminated by a Ser (-3),  followed by a short pro-region, 
Gln-Glu. The cDNA sequence confirms the position of the 
Cys residues and indicates that Ts ~¢ is not amidated: the 
codon encoding the last amino acid residue is followed by a 
stop codon, and not a codon encoding a Gly which is neces- 
sary for C-terminal amidation [15,20]. 
Ts ~¢ was compared to other scorpion peptidyl blockers of 
K + channels. The positions of the Cys residues are the same 
in all these molecules. Ts 1¢ shows 29% of sequence identity 
(Fig. 3) with the two other peptidyl blockers of the SKCa 
channel able to compete for the apamin binding site, i.e. 
LTX1 and P05, both of 31 amino acid residues long. Gly 26 
and Lys 27 are present in all these toxins. Ts 1< is more similar 
to the 37-38 residues long scorpion toxins able to block non- 
apamin-sensitive K + channels: for example, 46% identity be- 
tween Ts ~ and Ts TX-Kct [22], purified from the same ve- 
nom, 32% of identity with ChTX and 38% with KTX. The 
largest differences are in the C-terminal part: (1) Ts 1< is short- 
er than these other toxins; (2) in a highly conserved region 
(i.e. residues 26-32), involved in channel recognition [3- 
5,12,23]. Ts ~ contains Thr 29 instead of Met and Arg 32 instead 
of Lys. This could explain why Ts n did not compete (up to 
0.1 ktM) with [nSI]KTX bound to its receptor in rat brain 
synaptosomes (not shown). 
A conformational model of Ts 1< was designed from se- 
quence alignments with ChTX [19]. The positions of the six 
half-cystines were used as topological references (Fig. 4). The 
conformation of Ts 1< could be similar to that of ChTX: the 
t~-helix runs from residue 11 to 18 and the three-strand anti- 
parallel 13-sheet is made of sequences 2-4, 25-29 and 32-36. 
The final model has a total energy of -769 kcal/mol and is 
geometrically correct. Recognition by apamin, P05 and LTX 1 
of their receptor depends primarily on electrostatic nterac- 
tions involving the positive charge carried by the side chains 
of the a-helix. They are: Arg13-Arg 14 for apamin [6], Arg 6- 
Arg 7 for P05 [9], ArgZ-Arg 13 for LTX 1 [8,11]. Thus Arg 6 and 
Arg 9 of Ts 1< may be involved in recognition of the apamin 
binding site. Even if Arg 6 and Arg 9, as well as Lys is and 
Lys 19, are located on either side of the a-helix, they would 
nevertheless provide a highly basic exposed surface, possibly 
able to recognize the apamin binding site. Analogs obtained 
__K18 
~K19 
Fig. 4. Modelling of Ts 1< by molecular dynamics. Comparison of the structure of P05 (right side) and the Ts 1¢ model (left side). Cot atoms 
and side chains of interest (see text) are displayed. 
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by heterologous expression or chemical synthesis would be 
useful for investigating these possibilities. 
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